BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Policy

  GlaxoSmithKline and Ligand Pharmaceuticals Inc. Promacta(R) (Eltrombopag) Receives Unanimous Recommendation By FDA Advisory Panel

  June 2, 2008

   · 

  4 min read
• Drug Development

  Genomic Health, Inc. Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies; Results from Gene Identification Studies Support Further Exploration of Possible Tests to Predict Response to Targeted Therapies for Colon and Br

  June 2, 2008

   · 

  6 min read
• Celgene Corporation Withdraws Revlimid Application In Europe Following Negative Recommendation

  June 2, 2008

   · 

  4 min read
• Drug Development

  EntreMed, Inc.'s ENMD-2076 Demonstrates Antitumor Activity in Multiple Myeloma Model

  June 2, 2008

   · 

  4 min read
• Drug Development

  Oncolytics Biotech Inc. Announces Encouraging Phase II Sarcoma Study Results

  June 2, 2008

   · 

  1 min read
• Policy

  Merck KGaA’s Erbitux Gets EU Backing for Wider Use

  June 2, 2008

   · 

  1 min read
• Deals

  Mylan Inc. Acquires Central Eastern European Generics Businesses of Merck KGaA

  June 2, 2008

   · 

  2 min read
• BioCapital

  BioSpace Releases the 2008 BioCapital™ Hotbed Campaign

  June 2, 2008

   · 

  2 min read
• Drug Development

  Major Independent Trial Demonstrates Significant Anticancer Benefit Of Novartis AG Zometa In Women With Early-Stage Breast Cancer

  June 2, 2008

   · 

  1 min read
• Drug Development

  Merck KGaA Cancer Drug Erbitux Seen Limited Threat To Roche Holding AG and Genentech, Inc. Avastin

  June 2, 2008

   · 

  1 min read